Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Articles

PharmSource report addresses how the opportunity for antibody drug conjugates measures up to the bio/pharma industry’s expectations.

ADC Risk Vs. Payoff for CMO Industry

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Smart glasses enhance remote troubleshooting and process management for pharmaceutical manufacturing.

Harnessing the Potential of Smart Glasses

3M Drug Delivery Systems, Ei Solutionworks, IDT Biologika join CMO/CDMO association

PBOA Adds Members and Trustees

When implementing disposable technology for aseptic processing, considerations include material compatibility, material sourcing, facility layout, and training.

Best Practices: Using Single-Use Systems in Aseptic Processing

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Heightened global uncertainty could slow bio/pharma development activity.Bio/pharmaceutical companies, and the companies that serve them, tend to think they are immune from broader macroeconomic and political developments. As populations age, emerging middle classes expand, and scientific knowledge progresses, research on new drugs and demand for new therapies seem to follow an inexorably upward trend.

Macro Matters

Catalent plans a $4.6 million investment to expand secondary packaging and storage in Asia.

Catalent Expands Singapore Clinical Trials Hub

Sustainable harvesting combined with CMO expertise helped Centroflora CMS ensure supply continuity after it acquired Boehringer Ingelheim's non-captive API phytochemicals portfolio.

Success Story: Transferring a Phytochemical API Portfolio

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Steven Denham, director of biostatistics at MPI Research, discusses the impact the Standard for Exchange of Nonclinical Data may have on the pharmaceutical industry.

The Impact of SEND on the Pharmaceutical Industry

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Mergers and acquisitions have changed the shape of the contract services market as big players seek to build full-service capabilities.

Under New Ownership: Consolidation Reshapes Contract Services Market

Agnes Shanley is senior editor of Pharmaceutical Technology.

Transparent communications, both qualitative and quantitative data, and a clear understanding of each other’s needs are keys to collaborating on better product quality.